Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

Medicina (Kaunas, Lithuania)·2026
Same author

Italian live Delphi consensus on indications, peri-procedural management, technique, and learning curve of convective water vapor thermal therapy (Rezum™) in men with LUTS/BPH.

Urologia·2026
Same author

Editorial Comment on "Decision Curve Analysis-Based Risk-Adaptive Strategy for Individualizing Cystoscopy Decisions in Patients With Primary Microscopic Hematuria".

International journal of urology : official journal of the Japanese Urological Association·2025
Same author

Management of urinary stones by experts in stone disease (ESD 2025).

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2025
Same author

The feasibility and acceptability of a (mobile) application for men with lower urinary tract symptoms: a pilot study.

Minerva urology and nephrology·2025
Same author

Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.

JAMA network open·2025

Related Experiment Video

Updated: Apr 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K

Prostate-specific antigen screening, why have the guidelines changed?

Petros Sountoulides1, Georgios Moutzouris

  • 1Urology Department, General Hospital of Veria, Greece.

Expert Review of Anticancer Therapy
|October 14, 2014
PubMed
Summary
This summary is machine-generated.

Prostate cancer (PCa) screening, primarily via PSA tests, has improved survival rates but lacks accuracy. This leads to unnecessary biopsies and treatments for low-risk cancers, increasing patient morbidity.

Keywords:
PSAearly diagnosisovertreatmentprostate cancerscreeningsurvival

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

8.4K

Related Experiment Videos

Last Updated: Apr 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

8.4K

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer (PCa) is a significant health concern in Western countries, with rising incidence and high mortality rates.
  • Despite increasing PCa diagnoses, mortality rates are declining, largely due to screening implementation.
  • Current screening methods, mainly serum prostate-specific antigen (PSA) testing, suffer from suboptimal diagnostic accuracy.

Purpose of the Study:

  • To critically evaluate the advantages and disadvantages of prostate cancer screening.
  • To discuss the implications of recent guideline modifications for early PCa diagnosis.
  • To inform clinical practice and patient decision-making regarding PCa screening.

Main Methods:

  • Review of current literature on prostate cancer screening efficacy and accuracy.
  • Analysis of diagnostic performance of PSA testing.
  • Examination of recent changes in clinical guidelines for PCa early detection.

Main Results:

  • PCa screening has contributed to a decline in cancer-related deaths.
  • Inaccurate screening leads to a significant number of unnecessary biopsies.
  • Overdiagnosis and overtreatment of low-risk PCa result in added morbidity without survival benefits.

Conclusions:

  • The benefits of PCa screening must be weighed against its limitations, including overdiagnosis and overtreatment.
  • Refined screening strategies and diagnostic tools are needed to improve accuracy and reduce patient harm.
  • Ongoing evaluation of screening guidelines is essential for optimizing PCa management.